Benesch is pleased to announce its role in advising Currier Plastics in its recent investment partnership with Sheridan Capital Partners. This transaction marks a significant milestone for Currier, equipping the company to accelerate growth, pursue strategic mergers and acquisitions, and enhance its ability to deliver high-quality manufacturing solutions to customers across the healthcare and life sciences sectors.
Headquartered in Auburn, N.Y., Currier is a leading manufacturer of custom precision plastic components for healthcare and life sciences applications. The company has earned a strong reputation for its advanced custom blow and injection molding to produce tight-tolerance components in ISO Class 7 and Class 8 cleanrooms. Currier also provides value-added services, including design engineering, material selection and assembly.
As part of the transaction, industry veteran Andrew McLean has been appointed CEO. McLean brings more than 25 years of leadership experience in the medical device and pharmaceutical industries, positioning Currier for its next phase of growth.
“We are proud to have supported Currier in this important partnership with Sheridan,” said Alan Rothenbuecher, a lead partner on the transaction, along with Ryan Williams. “Currier has long been recognized for its quality and innovation, and this partnership provides the resources to expand its reach in the healthcare and life sciences markets. We look forward to seeing the company’s continued success.”
The transaction also included support from the following attorneys:
- Dana Weiss
- Rick Tracanna
- Shanae Nelson
- Injune Park
- Owen Gomez
- Nicholas Meyerson
- Andrew Murphy
- Julia Rolniak
- Kara Sturtz
- Melissa Grim
- Adam Primm
- Matt Delguyd
- Robert Marchant
- Dan Marks
- Shivdutt Trivedi
- Chelsea Wender
- Laura Sugarman
- Michael Swearengen
- Alyssa Roberts
- Kelly Noll
- Nisha Patel
- Aslam Rawoof
- Christopher Razek
- Scott Humphrey
- Christina Hultsch
Visit the Currier website to learn more.